Filtered By:
Condition: Heart Disease
Procedure: Heart Transplant
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 189 results found since Jan 2013.
Development of a Mobile Application Platform for Self-Management of Obesity Using Artificial Intelligence Techniques
Int J Telemed Appl. 2021 Aug 27;2021:6624057. doi: 10.1155/2021/6624057. eCollection 2021.ABSTRACTObesity is a major global health challenge and a risk factor for the leading causes of death, including heart disease, stroke, diabetes, and several types of cancer. Attempts to manage and regulate obesity have led to the implementation of various dietary regulatory initiatives to provide information on the calorie contents of meals. Although knowledge of the calorie content is useful for meal planning, it is not sufficient as other factors, including health status (diabetes, hypertension, etc.) and level of physical activity,...
Source: International Journal of Telemedicine and Applications - September 6, 2021 Category: Information Technology Authors: Sylvester M Sefa-Yeboah Kwabena Osei Annor Valencia J Koomson Firibu K Saalia Matilda Steiner-Asiedu Godfrey A Mills Source Type: research
Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with congenita...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
